The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho.

scientific article

The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1242/JCS.00640
P698PubMed publication ID12829746
P5875ResearchGate publication ID10687699

P50authorGrazia TammaQ43287339
Giovanna ValentiQ57335103
P2093author name stringMichael Schaefer
Burkhard Wiesner
Jens Furkert
Enno Klussmann
Walter Rosenthal
Alexander Oksche
Daniel Hahm
P433issuePt 16
P407language of work or nameEnglishQ1860
P921main subjectAVPQ12009087
prostaglandin E2Q416554
P304page(s)3285-3294
P577publication date2003-06-26
P1433published inJournal of Cell ScienceQ1524177
P1476titleThe prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho
P478volume116

Reverse relations

cites work (P2860)
Q42486834Adipocytes support cAMP-dependent translocation of aquaporin-2 from intracellular sites distinct from the insulin-responsive GLUT4 storage compartment.
Q45220032Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus
Q47699526An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells.
Q37681294Aquaporins in kidney pathophysiology
Q42511031Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression.
Q38022489Cell biology of vasopressin-regulated aquaporin-2 trafficking.
Q37970634Cell culture models and animal models for studying the patho-physiological role of renal aquaporins.
Q38223323Chronic kidney disease: targeting prostaglandin E2 receptors
Q36131354Clinical update on renal aquaporins
Q42098252Culturing primary rat inner medullary collecting duct cells
Q43182529Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney
Q36433783Drosophila Fascin is a novel downstream target of prostaglandin signaling during actin remodeling
Q38152961Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders
Q37489124Dysregulation of Renal Cyclooxygenase-2 in Rats with Lithium-induced Nephrogenic Diabetes Insipidus
Q26851156E-type prostanoid receptor 4 (EP4) in disease and therapy
Q34373002EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins
Q94467201Fascin regulates protrusions and delamination to mediate invasive, collective cell migration in vivo
Q93109484Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking
Q35178606Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice
Q34911441Heat shock proteins modulate keloid formation
Q28566309Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells
Q33732150Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels
Q39957663Involvement of non-conserved residues important for PGE2 binding to the constrained EP3 eLP2 using NMR and site-directed mutagenesis
Q39795875Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells
Q26740554Nuclear Receptor Regulation of Aquaporin-2 in the Kidney
Q47291983PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.
Q26771378Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
Q37145917Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption
Q47258262Prostaglandin E2 as a Regulator of Immunity to Pathogens.
Q48239629Prostaglandin E2 inhibits vasotocin-induced osmotic water permeability in the frog urinary bladder by EP1-receptor-mediated activation of NO/cGMP pathway.
Q36611067Prostaglandin E2 receptor distribution and function in the gastrointestinal tract
Q50128233Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
Q30651049Prostaglandins regulate nuclear localization of Fascin and its function in nucleolar architecture
Q37533694Prostaglandins temporally regulate cytoplasmic actin bundle formation during Drosophila oogenesis
Q30552150Quantitative apical membrane proteomics reveals vasopressin-induced actin dynamics in collecting duct cells
Q28578507Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking
Q36465879Regulation of aquaporin-2 in the kidney: A molecular mechanism of body-water homeostasis
Q52573334Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.
Q26768170The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases
Q37027311The role of actin remodeling in the trafficking of intracellular vesicles, transporters, and channels: focusing on aquaporin-2.
Q48436567Urine concentrating defect in prostaglandin EP1-deficient mice

Search more.